DarioHealth (DRIO) Gains from Investment Securities (2016 - 2025)
DarioHealth filings provide 9 years of Gains from Investment Securities readings, the most recent being $723000.0 for Q4 2025.
- On a quarterly basis, Gains from Investment Securities fell 94.76% to $723000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $73000.0, a 100.85% increase, with the full-year FY2025 number at $73000.0, down 82.94% from a year prior.
- Gains from Investment Securities hit $723000.0 in Q4 2025 for DarioHealth, up from $175000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $13.8 million in Q4 2024 to a low of -$13.3 million in Q3 2024.
- Median Gains from Investment Securities over the past 4 years was $61000.0 (2024), compared with a mean of -$506133.3.
- The widest YoY moves for Gains from Investment Securities: up 2117.25% in 2024, down 11376.25% in 2024.
- DarioHealth's Gains from Investment Securities stood at $92000.0 in 2022, then plummeted by 843.48% to -$684000.0 in 2023, then surged by 2117.25% to $13.8 million in 2024, then tumbled by 94.76% to $723000.0 in 2025.
- The last three reported values for Gains from Investment Securities were $723000.0 (Q4 2025), $175000.0 (Q3 2025), and -$145000.0 (Q2 2025) per Business Quant data.